These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 14713345)
1. Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia. Quintos-Alagheband ML; White CW; Schwarz MA Antioxid Redox Signal; 2004 Feb; 6(1):137-45. PubMed ID: 14713345 [TBL] [Abstract][Full Text] [Related]
2. Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II). Lal CV; Schwarz MA Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):180-8. PubMed ID: 24619875 [TBL] [Abstract][Full Text] [Related]
3. Potential role for antiangiogenic proteins in the myocardial infarction repair process. Thompson JL; Ryan JA; Barr ML; Franc B; Starnes VA; Schwarz MA J Surg Res; 2004 Jan; 116(1):156-64. PubMed ID: 14732363 [TBL] [Abstract][Full Text] [Related]
4. EMAP II: a modulator of neovascularization in the developing lung. Schwarz M; Lee M; Zhang F; Zhao J; Jin Y; Smith S; Bhuva J; Stern D; Warburton D; Starnes V Am J Physiol; 1999 Feb; 276(2):L365-75. PubMed ID: 9950900 [TBL] [Abstract][Full Text] [Related]
5. Temporo-spatial distribution of endothelial-monocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryo. Zhang F; Schwarz MA Dev Dyn; 2000 Jul; 218(3):490-8. PubMed ID: 10878614 [TBL] [Abstract][Full Text] [Related]
6. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Subramaniam M; Bausch C; Twomey A; Andreeva S; Yoder BA; Chang L; Crapo JD; Pierce RA; Cuttitta F; Sunday ME Am J Respir Crit Care Med; 2007 Nov; 176(9):902-12. PubMed ID: 17585105 [TBL] [Abstract][Full Text] [Related]
7. Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation. Journeay WS; Janardhan KS; Singh B Inflamm Res; 2007 May; 56(5):175-81. PubMed ID: 17393072 [TBL] [Abstract][Full Text] [Related]
8. Developmental regulation of p66Shc is altered by bronchopulmonary dysplasia in baboons and humans. Lee MK; Pryhuber GS; Schwarz MA; Smith SM; Pavlova Z; Sunday ME Am J Respir Crit Care Med; 2005 Jun; 171(12):1384-94. PubMed ID: 15778491 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal interactions are linked to neovascularization. Schwarz MA; Wan Z; Liu J; Lee MK Am J Respir Cell Mol Biol; 2004 Jun; 30(6):784-92. PubMed ID: 14672913 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo. Murray JC; Barnett G; Tas M; Jakobsen A; Brown J; Powe D; Clelland C Am J Pathol; 2000 Dec; 157(6):2045-53. PubMed ID: 11106577 [TBL] [Abstract][Full Text] [Related]
11. Lung manganese superoxide dismutase protein expression increases in the baboon model of bronchopulmonary dysplasia and is regulated at a posttranscriptional level. Clerch LB; Wright AE; Coalson JJ Pediatr Res; 1996 Feb; 39(2):253-8. PubMed ID: 8825796 [TBL] [Abstract][Full Text] [Related]
12. Bronchopulmonary dysplasia impairs L-type amino acid transporter-1 expression in human and baboon lung. Bao EL; Chystsiakova A; Brahmajothi MV; Sunday ME; Pavlisko EN; Wempe MF; Auten RL Pediatr Pulmonol; 2016 Oct; 51(10):1048-1056. PubMed ID: 26918397 [TBL] [Abstract][Full Text] [Related]
13. Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity. Lee DD; Lal CV; Persad EA; Lowe CW; Schwarz AM; Awasthi N; Schwarz RE; Schwarz MA Am J Respir Cell Mol Biol; 2016 Oct; 55(4):602-612. PubMed ID: 27254784 [TBL] [Abstract][Full Text] [Related]